Rachel Warren : If you currently own shares of Johnson & Johnson like I do, when the company splits, you will own shares of both Johnson & Johnson, the new pharmaceutical/medical device entity, as well as the new yet-to-be-named consumer health business. Unlike a stock split where you just own more shares of the company, you will now own two publicly traded businesses that are leaders in their respective markets.